Beta-blockers in the environment: Part II. Ecotoxicity study

Altenburger, 1990, Evaluation of the isobologram method for the assessment of mixtures of chemicals: combination effect studies with pesticides in algal biotests, Ecotoxicol Environ Saf, 20, 98, 10.1016/0147-6513(90)90049-B Amendola, 2000, Detection of beta-blockers in human urine by GC–MS–MS–EI: perspectives for the antidoping control, J Pharm Biomed Anal, 23, 211, 10.1016/S0731-7085(00)00271-5 Barbieri, 2012, Fate of β-blockers in aquifer material under nitrate reducing conditions: batch experiments, Chemosphere, 89, 1272, 10.1016/j.chemosphere.2012.05.019 British Pharmacopoeia Commission, 2005, British Pharmacopoeia Brooks, 2012 Caban, 2013, Dimethyl(3,3,3-trifluoropropyl)silyldiethylamine—a new silylating agent for the derivatization of β-blockers and β-agonists in environmental samples, Anal Chim Acta, 782, 78, 10.1016/j.aca.2013.04.018 Calleja, 1994, Comparative acute toxicity of the first 50 multicentre evaluation of in vitro cytotoxicity chemicals to aquatic non-vertebrates, Arch Environ Contam Toxicol, 26, 69, 10.1007/BF00212796 Claessens, 2013, Emerging contaminants in Belgian marine waters: single toxicant and mixture risks of pharmaceuticals, Mar Pollut Bull, 71, 41, 10.1016/j.marpolbul.2013.03.039 Cleuvers, 2003, Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects, Toxicol Lett, 142, 185, 10.1016/S0378-4274(03)00068-7 Cleuvers, 2005, Initial risk assessment for three beta-blockers found in the aquatic environment, Chemosphere, 59, 199, 10.1016/j.chemosphere.2004.11.090 Drost, 2007, Heavy metal toxicity to Lemna minor: studies on the time dependence of growth inhibition and the recovery after exposure, Chemosphere, 67, 36, 10.1016/j.chemosphere.2006.10.018 Dzialowski, 2006, Physiological and reproductive effects of beta adrenergic receptor antagonists in Daphnia magna, Arch Environ Contam Toxicol, 50, 503, 10.1007/s00244-005-0121-9 el-Sayed, 1998, Effects of some beta-adrenergic blockers on male fertility parameters in rates, Dtsch Tierarztl Wochenschr, 105, 10 Escher, 2006, Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach, Environ Sci Technol, 40, 7402, 10.1021/es052572v Faust, 2001, Predicting the joint algal toxicity of multi-component s-triazine mixtures at low-effect concentrations of individual toxicants, Aquat Toxicol, 56, 13, 10.1016/S0166-445X(01)00187-4 Faust, 2003, Joint algal toxicity of 16 dissimilarly acting chemicals is predictable by the concept of independent action, Aquat Toxicol, 63, 43, 10.1016/S0166-445X(02)00133-9 Ferrari, 2004, Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?, Environ Toxicol Chem, 23, 1344, 10.1897/03-246 Fraysse, 2005, Prediction and experimental validation of acute toxicity of ß-blockers in Ceriodaphnia dubia, Environ Toxicol Chem, 24, 2470, 10.1897/04-541R.1 Huggett, 2002, Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-blockers) on aquatic organisms, Arch Environ Contam Toxicol, 43, 229, 10.1007/s00244-002-1182-7 Huggett, 2003, Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent, Environ Pollut, 121, 199, 10.1016/S0269-7491(02)00226-9 ISO Guideline 8692, 1989 Kibbey, 2007, Adsorption of beta blockers to environmental surfaces, Environ Sci Technol, 41, 5349, 10.1021/es070152v 2004 Küster, 2009, Environmental risk assessment of human pharmaceuticals in the European Union: a case study with the β-blocker atenolol, Integr Environ Assess Manag, 6, 514 Lin Yu-Chen, 2009, Occurrence of pharmaceuticals in Taiwan's surface waters: impact of waste streams from hospitals and pharmaceutical production facilities, Sci Total Environ, 407, 3793, 10.1016/j.scitotenv.2009.03.009 Liu, 2009, Comparative aquatic toxicity of propranolol and its photodegradated mixtures: algae and rotifer screening, Environ Toxicol Chem, 28, 2622, 10.1897/09-071.1 Maurer, 2007, Elimination of beta-blockers in sewage treatment plants, Water Res, 41, 1614, 10.1016/j.watres.2007.01.004 Neumann-Hensel, 2006, Optimisation of the solid-contact test with Arthrobacter globiformis, J. Soils Sediments, 6, 201, 10.1065/jss2006.10.188 Owen, 2007, Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish, Aquat Toxicol, 82, 145, 10.1016/j.aquatox.2007.02.007 Palma, 2008, Acute toxicity of atrazine, endosulfan sulphate and chlorpyrifos to Vibrio fischeri, Thamnocephalus platyurus and Daphnia magna, Relative to their concentrations in surface waters from the Alentejo Region of Portugal, Bull Environ Contam Toxicol, 81, 485, 10.1007/s00128-008-9517-3 R Development Core Team, 2012 Rosen, 1988, Beta-blocker effects on sexual function in normal males, Arch Sex Behav, 17, 241, 10.1007/BF01541742 Santos, 2010, Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment, J Hazard Mater, 175, 45, 10.1016/j.jhazmat.2009.10.100 Scheurer, 2010, The challenge of analyzing beta-blocker drugs in sludge and wastewater, Anal Bioanal Chem, 396, 845, 10.1007/s00216-009-3225-7 Stanley, 2006, Enantiospecific toxicity of the beta-blocker propranolol to Daphnia magna and Pimephales promelas, Environ Toxicol Chem, 25, 1780, 10.1897/05-298R1.1 Teodorović, 2012, Myriophyllum aquaticum versus Lemna minor: sensitivity and recovery potential after exposure to atrazine, Environ Toxicol Chem, 31, 417, 10.1002/etc.748 The United States Pharmacopeial Convention, 2005, USP28-N-NF23, 1281 Wang, 2012, Photochemical fate of beta-blockers in NOM enriched waters, Sci Total Environ, 426, 289, 10.1016/j.scitotenv.2012.03.031 Wilde, 2013, Oxidation–coagulation of β-blockers by K2FeVIO4 in hospital wastewater: assessment of degradation products and biodegradability, Sci Total Environ, 452–453, 137, 10.1016/j.scitotenv.2013.01.059